Publicacións (40) Publicacións de MARÍA ASUNCIÓN PÉREZ-JACOISTE ASÍN

2024

  1. Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study

    Pathogens and Global Health, Vol. 118, Núm. 3, pp. 232-240

2023

  1. A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study

    American Journal of Transplantation, Vol. 23, Núm. 12, pp. 1949-1960

  2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7

  3. Disparities between Latinx migrants and Spanish natives in COVID-19 outcome in Madrid

    Pathogens and Global Health, Vol. 117, Núm. 6, pp. 590-595

  4. Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism

    Thrombosis Research, Vol. 232, pp. 54-61

  5. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

2021

  1. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

    European Respiratory Journal, Vol. 58, Núm. 1

  2. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

    International Journal of Infectious Diseases, Vol. 105, pp. 487-494

  3. Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1171.e1-1171.e7

  4. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

    International Journal of Infectious Diseases, Vol. 105, pp. 319-325

  5. Implementation of a program to improve influenza vaccination rates among medical students: a comparative study involving two university affiliated hospitals

    Human Vaccines and Immunotherapeutics, Vol. 17, Núm. 10, pp. 3662-3669

  6. Risk factors for the development of invasive aspergillosis after kidney transplantation: Systematic review and meta-analysis

    American Journal of Transplantation, Vol. 21, Núm. 2, pp. 703-716

  7. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842

  8. Visceral Kaposi's sarcoma

    Revista Clinica Espanola, Vol. 221, Núm. 3, pp. 180-181

2020

  1. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

    Thrombosis Update, Vol. 1

  2. Hepatic sinusoidal obstruction syndrome secondary to intravesical instillation of mitomycin-C

    Clinical Journal of Gastroenterology, Vol. 13, Núm. 2, pp. 271-275

  3. Imported cysticercosis in Spain: A retrospective case series from the +REDIVI Collaborative Network

    Travel Medicine and Infectious Disease, Vol. 37